
Join to view full profile
757 Westwood PlazaLos Angeles, CA 90095
Dr. Raddatz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2023 - 2027
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2021 - 2023
Vanderbilt University School of MedicineClass of 2021
Vanderbilt UniversityPhD, Biomedical Engineering, 2017 - 2020
Certifications & Licensure
CA State Medical License 2021 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Cardiotoxicity of T cell immunotherapies.Michael A Raddatz, Ashley F Stein-Merlob, Syed S Mahmood, Sarju Ganatra, Daniel Addison
Nature Reviews. Cardiology. 2026-09-01 - Lipidomics in aortic stenosis: beyond lipid lowering.Giuliana G Repetti, Michael A Raddatz
American Journal of Physiology. Heart and Circulatory Physiology. 2026-08-01 - Cardiogenic Shock From Chronic Immune Checkpoint Inhibitor Associated Myocarditis Causing Predominant Right Ventricular Failure.Harveen Sekhon, Pradeep S Rajendran, Katherine Hampilos, Michael A Raddatz, Cullen M Lilley
JACC. Cardiooncology. 2026-04-01
Press Mentions
Research Raises Hope for Treating Potentially Lethal Blood ConditionJune 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








